Literature DB >> 15584024

Tumorigenesis in p27/p53- and p18/p53-double null mice: functional collaboration between the pRb and p53 pathways.

Lorna A Damo1, Paul W Snyder, David S Franklin.   

Abstract

Mice lacking both p18(Ink4c) and p27(Kip1) develop a tumor spectrum similar to pRb(+/-) mice, and loss of p53 function accelerates tumorigenesis in pRb(+/-) mice. We hypothesized that codeletion of either p18 or p27 in conjunction with p53 deletion will also accelerate tumorigenesis. Mice lacking both p18 and p53 develop several tumors not reported in either single null genotype, including hepatocellular carcinoma, testicular choriocarcinoma, hemangiosarcoma, leiomyosarcoma, fibrosarcoma, and osteosarcoma. Mice lacking both p27 and p53 exhibit a decreased lifespan and develop unique tumors, including papillary carcinoma of the colon, hemangiosarcoma, and leiomyosarcoma. In both p18/p53 and p27/p53 double null genotypes, the incidence and spectra of tissues that develop lymphoma are also increased, as compared to the single null genotypes. The development of p27/p53 double null colon tumors correlates with secondary changes in cell-cycle protein expression and CDK (cyclin-dependent kinase) activity, perhaps contributing to the progression of colorectal cancer. We concluded that p18 and p27 can, not only functionally collaborate with one another, but also can independently collaborate with p53 to modulate the cell cycle and suppress tumorigenesis in a tissue-specific manner. Copyright 2004 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15584024     DOI: 10.1002/mc.20068

Source DB:  PubMed          Journal:  Mol Carcinog        ISSN: 0899-1987            Impact factor:   4.784


  8 in total

Review 1.  Single-nucleotide polymorphisms in the p53 signaling pathway.

Authors:  Lukasz F Grochola; Jorge Zeron-Medina; Sophie Mériaux; Gareth L Bond
Journal:  Cold Spring Harb Perspect Biol       Date:  2009-12-09       Impact factor: 10.005

2.  Cyclin dependent kinase inhibitors differentially modulate synergistic cytokine responsiveness of hematopoietic progenitor cells.

Authors:  Hal E Broxmeyer; David S Franklin; Scott Cooper; Giao Hangoc; Charlie Mantel
Journal:  Stem Cells Dev       Date:  2011-11-02       Impact factor: 3.272

Review 3.  Primary neoplasms of bones in mice: retrospective study and review of literature.

Authors:  A M Kavirayani; J P Sundberg; O Foreman
Journal:  Vet Pathol       Date:  2011-02-22       Impact factor: 2.221

Review 4.  Thyroid C-Cell Biology and Oncogenic Transformation.

Authors:  Gilbert J Cote; Elizabeth G Grubbs; Marie-Claude Hofmann
Journal:  Recent Results Cancer Res       Date:  2015

5.  Repression of Ah receptor and induction of transforming growth factor-beta genes in DEN-induced mouse liver tumors.

Authors:  Li Peng; Christopher N Mayhew; Michael Schnekenburger; Erik S Knudsen; Alvaro Puga
Journal:  Toxicology       Date:  2008-01-16       Impact factor: 4.221

Review 6.  Experimental models of hepatocellular carcinoma: developments and evolution.

Authors:  Long Wu; Zhao-You Tang; Yan Li
Journal:  J Cancer Res Clin Oncol       Date:  2009-04-28       Impact factor: 4.553

7.  Menin and p53 have non-synergistic effects on tumorigenesis in mice.

Authors:  Kelly A Loffler; Arne W Mould; Paul M Waring; Nicholas K Hayward; Graham F Kay
Journal:  BMC Cancer       Date:  2012-06-18       Impact factor: 4.430

Review 8.  Angiosarcoma of the breast, the unknown-a review of the current literature.

Authors:  Emanuela Esposito; Franca Avino; Raimondo di Giacomo; Ivana Donzelli; Ugo Marone; Maria Teresa Melucci; Chiara Rinaldo; Fulvio Ruffolo; Ruggero Saponara; Claudio Siani; Raffaele Tortoriello; Gerardo Botti; Massimo Rinaldo; Alfredo Fucito
Journal:  Transl Cancer Res       Date:  2019-10       Impact factor: 1.241

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.